Navigation Links
Vermillion Reports Third Quarter 2012 Results
Date:11/12/2012

the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.

A replay of the call will be available approximately two hours after the call and until November 26, 2012.

Toll-free replay number: 1-800-633-8284
International replay number: 1-402-977-9140
Replay pin number: 21607929

About OVA1
OVA1 is a blood test for pre-surgical assessment of ovarian tumors for malignancy, using a unique multi-biomarker approach. In a published clinical trial, OVA1 achieved 99% sensitivity in detecting epithelial ovarian cancers (EOC). This included 96% sensitivity for stage I EOC, the earliest and most curable EOC stage, compared with 57% for the conventional biomarker CA125.(1) In addition, OVA1 found 70% of malignancies missed by non-specialist pre-surgical assessment,(1) and it increased detection of malignancy over ACOG guidelines from 77% to 94%.(2) As the first protein-based, In Vitro Diagnostic Multi-Variate Index Assay (IVDMIA) cleared by the FDA, OVA1 also represents a new class of software-based diagnostics.

Citings:
1)
Ueland, FR, et al. Obstet Gynecol 2011:VOL 117, NO. 6, June 2011
2)
Miller R, et al. Obstet Gynecol 2011:VOL 117, NO. 6, June 2011

About Vermillion
Vermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, vascular medicine and women's health. Additional in
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Vermillion Sets Third Quarter 2012 Conference Call for Monday, November 12, 2012 at 4:30 p.m. ET
2. Vermillion to Present at the 2012 Gateway Conference on September 6
3. Vermillion Reports Second Quarter 2012 Results
4. Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
5. Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions
6. Vermillion Announces CEO Succession Plan
7. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
8. Omeros Corporation Reports Third Quarter 2012 Financial Results
9. VirtualScopics Reports 3rd Quarter 2012 Results
10. Neuland Labs Reports Second Quarter Fiscal Year 2013 Financial Results
11. GenVec Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... MUMBAI , July 4, 2015 ... the epidemics of hypertension, diabetes and thyroid disorders in ... free online educational platforms and a major conference dedicated ... Manage Diabetes Online , Manage ... - each developed and operated by EXCEMED ...
(Date:7/3/2015)... -- A global continuing medical education provider ... disorders in Latin America through ... to these diseases.      (Logo: http://photos.prnewswire.com/prnh/20150630/227033) , ... Hypertension Online and Manage Thyroid Online ... - combine the world,s top expertise with dynamic learning ...
(Date:7/3/2015)... -- Redwood Pharma AB has entered into ... in both the US and China ... supramolecular hydrogel technology in its lead chronic Dry Eye ... Broda technology offers many unique competitive benefits. At lower ... with low concentrations of polymer the system can be ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Central and South-East Asia With Medical Education 2Combating Three Major Chronic Diseases in Latin America With Medical Education 2Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2
... ASCO Showed Acceptable Tolerability Profile, ... Low Incidence of Grade 3 and 4 Neuropathy, ... eribulin mesylate (E7389) demonstrated activity in a,heavily pretreated population ... to results of a multi-center Phase II clinical,trial. The ...
... breadth of, collaboration with investigators worldwide to develop new treatments for ... diverse forms of cancer ... bisphosphonate, on relapse rate of patients with early-stage breast cancer, - Four ... first results of RECORD-1 study in renal cell ...
Cached Medicine Technology:Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10
(Date:7/3/2015)... , ... July 03, 2015 , ... ... to healthcare providers, has been retained to lead a national chief nursing ... the top-ranked executive search firms in the healthcare industry, B. E. Smith has ...
(Date:7/3/2015)... Lewisville, TX (PRWEB) , ... July 03, 2015 , ... ... in the United States, named Mariah N. Manzanares, MD as the new Medical Director ... the new facility medical director of our Frisco facility,” said Dr. James M. Muzzarelli, ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... sweetFrog Enterprises, ... Mississippi. The opening is the first sweetFrog store located in Mississippi. The premium frozen ... companies in 2014. , The store, located at 104 Railroad Avenue, New Albany, MS ...
(Date:7/2/2015)... ... 02, 2015 , ... When Walker Parking Consultants specified Kenall ... Minnesota, they knew it would save the university energy and maintenance costs. What ... total energy savings after installation was an impressive 89 percent, which resulted in ...
(Date:7/2/2015)... ... ... As Americans celebrate the Fourth of July outdoors this weekend, local physicians ... July is UV Safety Month, and physicians at American Family Care and AFC Doctors ... Experts say most skin cancers can be found early with regular skin exams. Physicians ...
Breaking Medicine News(10 mins):Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4
... Canadian study links regular alcohol consumption to six cancers , ... moderate or high amounts of alcohol over the course of ... -- but not all -- kinds of cancer, a new ... Canadian researchers, found that the more men drink, the greater ...
... , , , The poll results ... , , WASHINGTON, Aug. 7 A poll conducted ... planning to take precautions against the H1N1 virus, more than a third of ... , , (Logo: http://www.newscom.c ...
... , , , WHEATON, ... has awarded Marianjoy Rehabilitation Hospital a grant in the amount ... Continuing Care Program, which offers group classes for children with ... to help children gain and improve their motor, sensory, play, ...
... in prevention efforts, , FRIDAY, Aug. 7 (HealthDay News) -- ... of medical errors while in the hospital, a new study ... children hospitalized in 2005 at Seattle Children,s Hospital, nearly two-thirds ... to ensure there were no medical errors. , Parents whose ...
... Primate Research Center, Emory University, believe conventional vaccine strategies ... development of an effective AIDS vaccine. Based on studying ... propose an additional new approach to the AIDS vaccine ... issue of Nature Medicine . Their recommendations outline ...
... new information at 6- and 12-months-old, typically ... adults in their 20,s, according to a study ... Fagan,s "The prediction, from infancy, of adult IQ ... is receiving accolades. Mensa International, Limited,- the international organization ...
Cached Medicine News:Health News:Drinking Moderately or More Ups Men's Cancer Risk 2Health News:Drinking Moderately or More Ups Men's Cancer Risk 3Health News:Red Cross Poll Shows Parents Still Lack H1N1 Information From Schools 2Health News:DuPage Community Foundation Awards $15,000 Grant to Marianjoy Pediatric Continuing Care Program 2Health News:DuPage Community Foundation Awards $15,000 Grant to Marianjoy Pediatric Continuing Care Program 3Health News:When Kids Are Hospitalized, Parents Fret About Errors 2Health News:Yerkes researchers propose ambitious new strategies for AIDS vaccine research 2Health News:Yerkes researchers propose ambitious new strategies for AIDS vaccine research 3Health News:Ability to process information as a baby continues into adulthood 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: